FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-epcoritamab-bysp-relapsed-or-refractory-follicular-lymphoma?utm_medium=email&utm_source=govdelivery